Terry Buchmiller

Terry Buchmiller is a pediatric surgeon and researcher at Boston Children's Hospital, specializing in fetal surgery and congenital anomalies. His work focuses on in utero interventions for conditions such as intrauterine growth retardation (IUGR) and obstructive uropathy, using animal models to explore amniotic fluid supplementation and molecular mechanisms of fetal development.

His educational background includes:

• Medical School: University of California, Davis (1988)
• Residency: University of California, Los Angeles (1995)
• Fellowship: Pediatric Surgery, Boston Children's Hospital (1997)

Buchmiller's research interests center on fetal gastrointestinal and pulmonary development, particularly in the context of congenital diaphragmatic hernia (CDH), esophageal atresia, and renal obstruction. He investigates how epidermal growth factor (EGF) and other agents can enhance nutrient absorption and reverse growth retardation in fetal models. His lab also studies the reversal of pulmonary hypoplasia through amniotic fluid repletion in large animal models of oligohydramnios.

His recent publications span a wide range of topics, including CDH outcomes, ethical challenges in fetal surgery, ergonomic risks for pediatric surgeons, and long-term follow-up of neonatal surgical conditions. The research demonstrates a strong trend toward improving survival, understanding molecular pathways, and enhancing quality of life for patients with congenital anomalies.

Notable scientific contributions include:

• Development of fetal rabbit and sheep models for IUGR and obstructive uropathy
• Validation of amniotic fluid catheterization for in utero therapy
• Elucidation of EGF's role in fetal gut maturation
• Collaborative work with Dr. Dario Fauza on renal function markers

Buchmiller is actively involved in mentoring and professional development through the American Pediatric Surgical Association (APSA), where he contributes to coaching and peer support initiatives. His work integrates basic science with clinical outcomes, aiming to translate experimental findings into improved prenatal and neonatal care. He has not disclosed any personal labs or teams, but his research is conducted within the broader research infrastructure of Boston Children's Hospital.